Key Benefits:
Minister of Health and Sports,
Vu le Public Health Codeincluding article L. 5126-4;
Considering the amended decision of 17 December 2004 setting out the list provided for inArticle L. 5126-4 of the Public Health Code ;
Considering the opinion of the Director General of the French Health Products Agency dated 20 September 2010,
Stop it!
The schedule to the above-mentioned Order of 17 December 2004 is amended as follows:
At "6. Other drugs", the following specialties are added:
EPOPROSTENOL PANPHARMA 0.5 mg, powder and solvent for injectable solution 6 241 062 9 | PANMEDICA | PANPHARMA | 9354225 | EPOPROSTENOL PAN 0.5 MG FL + FL |
EPOPROSTENOL PANPHARMA 1.5 mg, powder and solvent for injectable solution 6 794 729 8 | PANMEDICA | PANPHARMA | 9354231 | EPOPROSTENOL PAN 1.5 MG FL + FL |
The Director General of Health is responsible for the execution of this Order, which will be published in the Official Journal of the French Republic.
Done in Paris, September 27, 2010.
For the Minister and by delegation:
Mission
Deputy Director
Policy on Practices
and health products,
C. Choma